Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FWP
CUSIPN/A
Phone45-3344-4242
Debt
Debt-to-Equity RatioN/A
Current Ratio5.22
Quick Ratio5.22
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.25 billion
Price / Sales0.11
Cash Flow$20.0714 per share
Price / Cash0.14
Book Value$1.90 per share
Price / Book1.48
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees12
Outstanding Shares47,180,000
Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions
What is Forward Pharma A/S's stock symbol?
Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."
How often does Forward Pharma A/S pay dividends? What is the dividend yield for Forward Pharma A/S?
Forward Pharma A/S declared an annual dividend on Thursday, August 24th. Investors of record on Thursday, September 7th will be paid a dividend of $22.903 per share on Monday, September 11th. The ex-dividend date is Wednesday, September 6th. View Forward Pharma A/S's Dividend History.
How were Forward Pharma A/S's earnings last quarter?
Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.
What price target have analysts set for FWP?
1 brokers have issued twelve-month price objectives for Forward Pharma A/S's shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate Forward Pharma A/S's stock price to reach $6.00 in the next year. View Analyst Ratings for Forward Pharma A/S.
Who are some of Forward Pharma A/S's key competitors?
Some companies that are related to Forward Pharma A/S include ZIOPHARM Oncology (ZIOP), Aurinia Pharmaceuticals (AUPH), Merus (MRUS), Verastem (VSTM), ArQule (ARQL), Sinovac Biotech (SVA), Depomed (DEPO), ZEALAND PHARMA/S (ZEAL), Concert Pharmaceuticals (CNCE), Clementia Pharmaceuticals (CMTA), Cytokinetics (CYTK), Synergy Pharmaceuticals (SGYP), Mersana Therapeutics (MRSN), Dermira (DERM) and GTX (GTXI).
Who are Forward Pharma A/S's key executives?
Forward Pharma A/S's management team includes the folowing people:
- Dr. Claus Bo Svendsen M.D., Ph.D., CEO & Principal Financial Officer (Age 41)
- Mr. Thomas Carbone, Principal Accounting Officer, VP of Fin. and Controller (Age 61)
Has Forward Pharma A/S been receiving favorable news coverage?
News headlines about FWP stock have trended positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Forward Pharma A/S earned a daily sentiment score of 0.34 on Accern's scale. They also assigned media coverage about the biotechnology company an impact score of 45.44 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
Who are Forward Pharma A/S's major shareholders?
Which major investors are selling Forward Pharma A/S stock?
Which major investors are buying Forward Pharma A/S stock?
How do I buy shares of Forward Pharma A/S?
Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Forward Pharma A/S's stock price today?
One share of FWP stock can currently be purchased for approximately $2.81.
How big of a company is Forward Pharma A/S?
Forward Pharma A/S has a market capitalization of $128.34 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 12 workers across the globe.
How can I contact Forward Pharma A/S?
Forward Pharma A/S's mailing address is Ostergade 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 45-3344-4242 or via email at [email protected]
MarketBeat Community Rating for Forward Pharma A/S (FWP)
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
